Arcadia Biosciences Inc
NASDAQ:RKDA

Watchlist Manager
Arcadia Biosciences Inc Logo
Arcadia Biosciences Inc
NASDAQ:RKDA
Watchlist
Price: 1.77 USD -3.28% Market Closed
Market Cap: $2.4m

Arcadia Biosciences Inc
Investor Relations

Arcadia Biosciences, Inc. is an agricultural biotechnology company which engages in the development of agricultural products for the improvement of the environment and human health. The company is headquartered in Davis, California and currently employs 58 full-time employees. The company went IPO on 2015-05-15. The firm is engaged in developing crop improvements, primarily in wheat, designed to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients, health and wellness products, and their viability for industrial applications. The company is using non-genetically modified (non-GMO) advanced breeding techniques to develop the products. The firm's product portfolio includes GoodWheat Consumer Products, Zola Coconut Water, ProVault Topical Pain Relief, SoulSpring Body Care and Saavy Naturals Body Care. Its GoodWheat portfolio of specialty wheat ingredients delivers health benefits with advanced nutritional profiles. ProVault’s tetrahydrocannabinol (THC)-free, cannabidiol (CBD)-infused blend of natural ingredients and fast-acting cooling agents are designed to relieve muscle and joint pain and soothe skin.

Show more
Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Last Earnings Call
Fiscal Period
Q1 2025
Call Date
May 8, 2025
AI Summary
Q1 2025

Zola Sales Growth: Zola Coconut Water sales increased 90% year-over-year in Q1 2025, far outpacing the broader coconut water category.

Distribution Expansion: New distribution for Zola grew 70% year-over-year, with additional placements expected to impact 2025 results.

Revenue & Margins: Total revenue rose 22% to about $1.2 million, and gross margin remained strong at 43%, though lower than last year.

Operating Expenses: Operating expenses decreased 16% year-over-year, even with nearly $0.5 million in transaction-related fees.

Legacy Business Exit: Arcadia monetized legacy patents for $750,000 in cash and eliminated a $1 million contingent liability and future royalty expenses.

Business Combination Update: The pending merger with Roosevelt Resources is progressing, now targeting a close around August 15 with a fixed 90-10 equity share ratio.

Key Financials
Total Revenue
$1.2 million
Zola Sales
not specified
Gross Margin
43%
Operating Expenses
not specified
Selling, General and Administrative Costs
$1.7 million
Cash Balance
$3.2 million
Inventory
$1.3 million
Earnings Call Recording
Other Earnings Calls

Management

Mr. Thomas J. Schaefer C.F.A.
CEO, President & Director
No Bio Available
Mr. Mark Kawakami
Chief Financial Officer
No Bio Available

Contacts

Address
CALIFORNIA
Davis
202 Cousteau Pl Ste 200
Contacts
+15307567077.0
arcadiabio.com